HilleVax (HLVX)
(Real Time Quote from BATS)
$13.05 USD
-0.03 (-0.23%)
Updated Apr 23, 2024 10:50 AM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Price, Consensus and EPS Surprise
HLVX 13.05 -0.03(-0.23%)
Will HLVX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for HLVX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HLVX
Wall Street Analysts Believe HilleVax, Inc. (HLVX) Could Rally 92.19%: Here's is How to Trade
HilleVax, Inc. (HLVX) Moves to Buy: Rationale Behind the Upgrade
HLVX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Does HilleVax, Inc. (HLVX) Have the Potential to Rally 107.23% as Wall Street Analysts Expect?
Wall Street Analysts Predict a 56.76% Upside in HilleVax, Inc. (HLVX): Here's What You Should Know
How Much Upside is Left in HilleVax, Inc. (HLVX)? Wall Street Analysts Think 87.76%
Other News for HLVX
Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX)
HLVX Crosses Below Key Moving Average Level
Analysts Offer Insights on Healthcare Companies: AbSci (ABSI), HilleVax, Inc (HLVX) and Cabaletta Bio (CABA)
HilleVax: Mid-2024 Data Is Crucial Inflection Point For Continued Valuation
Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX)